Skip to main content


Health

During a phase one clinical trial of a new treatment for MS patients, researchers were able to curtail the body's attacks on myelin by 50 to 75 percent, while sustaining the functionality of the rest of the immune system.
394 of 1602



Newsletter Sign Up

Daily Readings

Reading 1, Revelation 11:4-12
These are the two olive trees and the two lamps in attendance ... Read More

Psalm, Psalms 144:1, 2, 9-10
[Of David] Blessed be Yahweh, my rock, who trains my hands for ... Read More

Gospel, Luke 20:27-40
Some Sadducees -- those who argue that there is no resurrection ... Read More

Saint of the Day

November 22 Saint of the Day

St. Cecilia
November 22: In the fourth century appeared a Greek religious romance on the ... Read More